Structure-Function analysis of the CTLA-4 interaction with PP2A

por Teft, Wendy A, Chau, Thu A, Madrenas, Joaquín
Publicado 2009

Profound reduction in tamoxifen active metabolite endoxifen in a breast cancer patient treated with rifampin prior to initiation of an anti-TNFα biologic for ulcerative colitis: a...

por Henderson, Sara L., Teft, Wendy A., Kim, Richard B.
Publicado 2016

Attenuation of bile acid-mediated FXR and PXR activation in patients with Crohn’s disease

por Wilson, Aze, Almousa, Ahmed, Teft, Wendy A., Kim, Richard B.
Publicado 2020

Pharmacogenomics Guided-Personalization of Warfarin and Tamoxifen

por Wigle, Theodore J., Jansen, Laura E., Teft, Wendy A., Kim, Richard B.
Publicado 2017

Targeted next generation sequencing as a tool for precision medicine

por Gulilat, Markus, Lamb, Tyler, Teft, Wendy A., Wang, Jian, Dron, Jacqueline S., Robinson, John F., Tirona, Rommel G., Hegele, Robert A., Kim, Richard B., Schwarz, Ute I.
Publicado 2019

Impact of pretreatment dihydropyrimidine dehydrogenase genotype‐guided fluoropyrimidine dosing on chemotherapy associated adverse events

por Wigle, Theodore J., Povitz, Brandi L., Medwid, Samantha, Teft, Wendy A., Legan, Robin M., Lenehan, John, Nevison, Stephanie, Panuganty, Veera, Keller, Denise, Mailloux, Jaymie, Siebring, Victoria, Sarma, Sisira, Choi, Yun‐hee, Welch, Stephen, Winquist, Eric, Schwarz, Ute I., Kim, Richard B.
Publicado 2021